Current Cancer Drug Targets
Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Cancer Drug Targets, Volume 18 - Number 3
Biography
Review Article
Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges
, 18(3): 222 - 230J. Barroca-Ferreira , J.P. Pais, M.M. Santos, A.M. Goncalves, I.M. Gomes, I. Sousa, S.M. Rocha, L.A. Passarinha and C.J. Maia*
DOI: 10.2174/1568009617666170427103732
Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges
Review Article
Obesity and Cancer: Biological Links and Treatment Implications
, 18(3): 231 - 238Alessandro Ottaiano*, Chiara De Divitiis, Monica Capozzi, Antonio Avallone, Carmen Pisano, Sandro Pignata and Salvatore Tafuto
DOI: 10.2174/1568009617666170330125619
Obesity and Cancer: Biological Links and Treatment Implications
Review Article
Elaborating the Role of Natural Products on the Regulation of Autophagy and their Potentials in Breast Cancer Therapy
, 18(3): 239 - 255Xunian Zhou, Grace Gar-Lee Yue, Stephen Kwok-Wing Tsui, Jianxin Pu, Kwok-Pui Fung and Clara Bik-San Lau*
DOI: 10.2174/1568009617666170330124819
Elaborating the Role of Natural Products on the Regulation of Autophagy and their Potentials in Breast Cancer Therapy
Review Article
The Complexity of DEK Signaling in Cancer Progression
, 18(3): 256 - 265Yong Teng*, Liwei lang and Catherine E. Jauregui
DOI: 10.2174/1568009617666170522094730
The Complexity of DEK Signaling in Cancer Progression
Review Article
MicroRNA Key to Angiogenesis Regulation: MiRNA Biology and Therapy
, 18(3): 266 - 277Ankit Tiwari, Bratati Mukherjee and Manjusha Dixit*
DOI: 10.2174/1568009617666170630142725
MicroRNA Key to Angiogenesis Regulation: MiRNA Biology and Therapy
Research Article
Effects of PHA-665752 and Cetuximab Combination Treatment on In Vitro and Murine Xenograft Growth of Human Colorectal Cancer Cells with KRAS or BRAF Mutations
, 18(3): 278 - 286Yi-Tao Jia, Dong-hai Yang, Zhaolong Zhao, Xiao-Hui Bi, Wei-Hua Han, Bo Feng, Jie Zhi, Bin Gu, Zhihui Duan, Jian-Hua Wu, Ying-Chao Ju, Ming-Xia Wang and Zhong-Xin Li*
DOI: 10.2174/1568009617666170330112841
Effects of PHA-665752 and Cetuximab Combination Treatment on In Vitro and Murine Xenograft Growth of Human Colorectal Cancer Cells with KRAS or BRAF Mutations
Research Article
HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation
, 18(3): 287 - 294Gustavo Alencastro Veiga Cruzeiro, Maristella Bergamo dos Reis, Vanessa Silva Silveira, Regia Caroline Peixoto Lira, Carlos Gilberto Carlotti Jr, Luciano Neder, Ricardo Santos Oliveira, Jose Andres Yunes, Silvia Regina Brandalise, Simone Aguiar, Agda Karina Eterovic, Luiz Gonzaga Tone, Carlos Alberto Scrideli* and Elvis Terci Valera
DOI: 10.2174/1568009617666170315162525
HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation
Research Article
Autophagy Inhibition in Childhood Nephroblastoma and the Therapeutic Significance
, 18(3): 295 - 303Lin-Jie Li , Yi-Long Wang, Lin-Qing Yuan, Wei-Zhong Gu, Kun Zhu, Min Yang, Duo Zhou, Yao Lv, Min-Ju Li, Zheng-Yan Zhao, Jin-Hu Wang* and Xi Chen*
DOI: 10.2174/1568009617666170330105433
Autophagy Inhibition in Childhood Nephroblastoma and the Therapeutic Significance
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75
Webmaster Contact: info@benthamscience.net